Mexiletine Shortens the QT Interval in Patients with Potassium Channel-Mediated Type 2 Long QT Syndrome

J. Martijn Bos, Lia Crotti, Ram K. Rohatgi, Silvia Castelletti, Federica Dagradi, Peter J. Schwartz, Michael J. Ackerman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint Dive into the research topics of 'Mexiletine Shortens the QT Interval in Patients with Potassium Channel-Mediated Type 2 Long QT Syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences